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Trophoblast hypoxia and injury, key components of placental dysfunction, are associated with fetal growth restriction and other complications of pregnancy. Accumulation of lipid droplets has been found in hypoxic nonplacental cells. Unique to pregnancy, lipid accumulation in the placenta might perturb lipid transport to the fetus. We tested the hypothesis that hypoxia leads to accumulation of lipid droplets in human trophoblasts and that trophoblastic PLIN proteins play a key role in this process. We found that hypoxia promotes the accumulation of lipid droplets in primary human trophoblasts. A similar accretion of lipid droplets was found in placental villi in vivo from pregnancies complicated by fetal growth restriction. In both situations, these changes were associated with an increased level of cellular triglycerides. Exposure of trophoblasts to hypoxia led to reduced fatty acid efflux and oxidation with no change in fatty acid uptake or synthesis. We further found that hypoxia markedly stimulated PLIN2 mRNA synthesis and protein expression, which colocalized to lipid droplets. Knockdown of PLIN2, but not PLIN3, enhanced trophoblast apoptotic death, and overexpression of PLIN2 promoted cell viability. Collectively, our data indicate that hypoxia enhances trophoblastic lipid retention in the form of lipid droplets and that PLIN2 plays a key role in this process and in trophoblast defense against apoptotic death. These findings also imply that this protective mechanism may lead to diminished trafficking of lipids to the developing fetus. (Endocrinology 159: 3937-3949, 2018) F etal growth and development require the supply of metabolic fuels, including lipids (1) . This is particularly germane during the period of accelerated fetal growth, when fetal fat accretion rises from midgestation to term (2, 3) . Newborns that exhibited growth restriction attributed to placental hypoperfusion or nutrient deprivation exhibit disproportionately reduced fat mass compared with appropriately grown newborns (4) (5) (6) . This is associated with lower levels of polyunsaturated fatty acids (PUFAs) that are important for neuronal development (7) . In eutherian mammals, the placenta plays a central role in the uptake of metabolic fuels, their storage, metabolism, and transport for efflux to the fetal circulation (8) (9) (10) . These processes are tightly regulated to ensure proper fetal development. Indeed, placental dysfunction is the most common cause of fetal growth restriction (FGR) and is associated with stillbirths (11) . Whereas physiological hypoxia characterizes the early placenta, before maternal blood begins to perfuse the intervillous space, after 10 to 14 weeks of human pregnancy, PO 2 rises from 15 to 20 mm Hg to 50 to 55 mm Hg (12) . Placental hypoxia after that gestational age may lead to villous injury (13, 14) . Accordingly, exposure of cultured third trimester trophoblasts to hypoxia (PO 2 ,1%) is commonly used to investigate hypoperfusion-induced villous injury (15) (16) (17) (18) (19) (20) .
During pregnancy, the mother accumulates triglycerides until the third trimester, when more fat catabolism occurs, with higher activity of maternal hormonesensitive lipase (21) . Although the fetal liver and adipose tissue are capable of de novo fatty acid synthesis, the supply of triglycerides and, particularly, the delivery of PUFAs to the fetus is necessary and is preserved by preferential uptake of PUFAs across the placenta (21, 22) . Maternal blood lipoproteins are hydrolyzed by placental epithelial hydrolases/lipoprotein lipases, yielding free fatty acids (FFAs) that cross the trophoblastic microvillous membrane in a process supported by FABPpm, CD36, and FATP (21, (23) (24) (25) (26) . Cytoplasmic FFAs bound to fatty acid-binding proteins are metabolized or stored in lipid droplets, which actively store neutral lipids (triglycerides, cholesteryl esters, retinol esters, and ether lipids) for cellular energy, membrane building blocks, and protection against lipotoxicity (27) (28) (29) (30) (31) . Lipid droplets, which measure 0.01 to 0.4 mm in diameter, are formed from cellular membranes and are encased within a layer of amphipathic phospholipids and coated by proteins that regulate the assembly, maintenance, and composition of lipid droplets, as well as their trafficking, lipolysis, and efflux (32, 33) .
Although the mechanisms underlying their dynamics are largely unknown, lipid droplets are known to be maintained by lipid droplet associated proteins (34) (35) (36) . The lipid droplet protein PLIN1 (perilipin) is expressed primarily in adipocytes and steroidogenic cells and plays an important role in maintaining droplet integrity and in the prevention of lipolysis (37, 38) . PLIN2 (adipophilin, ADFP, ADRP) and PLIN3 (TIP47, PP17) are ubiquitously expressed (39, 40) . PLIN2 is a known marker of cellular lipid accumulation (41) and directly interacts with lipids on the droplet surface (42, 43) . PLIN2, along with PLIN4 (S3-12) and PLIN5 (Oxpat, LSDP5, MLDP, PAT1), support lipid droplet formation and reduce degradation (44, 45) . Lipolysis and breakdown of lipid droplets are mediated through the action of lipases, including hormone-sensitive lipase and adipose triglyceride lipase (46, 47) , through their interaction with PLIN proteins and cofactors (47, 48) .
Placental trophoblasts are unique in their regulation of lipid transport from one organism (mother) to another (fetus). Lipids are stored in the human and rodent placenta (49) , and PLIN proteins (specifically PLIN2 and PLIN3) are expressed in the placenta (50) (51) (52) (53) (54) (55) . Thus, dysregulation of placental lipid trafficking may have major consequences for trophoblast biology and the critical supply of metabolic fuels to the fetus. Oversupply of FFAs may predispose trophoblasts to excessive lipid peroxidation, which may disrupt membrane integrity and metabolic functions, damage DNA, with subsequent endoplasmic reticulum stress, inflammation, mitochondrial dysfunction, and cell damage (56, 57 ). Yet such accumulation may also reduce the trafficking of lipidic fuels to the developing fetus. To assess the accumulation of lipids in injured human trophoblasts and define the role of trophoblastic PLIN proteins in this process, we tested the hypothesis that hypoxia leads to the accumulation of lipids in placental lipid droplets and that trophoblastic PLIN proteins play a key role in this process.
Materials and Methods

Placental samples
Placentas and placental specimens used in our studies were collected at Washington University in St Louis and at MageeWomens Hospital at the University of Pittsburgh. All placentas were obtained after term or near-term delivery, using a protocol that was approved by the institutional review boards at Washington University and the University of Pittsburgh. Placental biopsies were obtained from deliveries (n = 4) of discordant dizygotic twins (one with normal growth, the other with FGR) or deliveries (n = 5) of small-or appropriatefor-gestational-age fetuses, including two sets of appropriately grown twins. We have previously detailed these pregnancies and the definition of FGR for pregnancies included in our studies (58) .
Cell culture
Primary human trophoblasts (PHTs) were prepared from term human placentas after uncomplicated labor and delivery using the trypsin-DNase-dispase/Percoll method as previously described (59) , with modifications (20) . Cultures were plated at a density of 350,000 cells/cm 2 and maintained as previously described (20) . In some experiments, trophoblasts were grown in Ham/Waymouth medium, composed of equal volumes of Ham F12 medium and Waymouth medium, or Medium-199 (17), both supplemented as described (20) . Cultures were maintained at 37°C in a 5% CO 2 and 20% O 2 atmosphere. For the hypoxia experiments, 4 hours after seeding (defined as time 0 for our standard and hypoxia experiments), the plates were transferred to a hypoxia chamber, as we have described (20) . Briefly, culture in hypoxic conditions in all experiments detailed here was maintained in a hermetically enclosed incubator (Thermo Electron, Marietta, OH) that provided a hypoxic atmosphere, defined as ,1% O 2 (achieved with delivery of a gas mixture of 5% CO 2 , 10% H 2 , and 85% N 2 ), and monitored continuously using a sensor connected to a data acquisition module (Scope; Data Translation, Marlboro, MA). In other experiments, in which we focused on the effect of hypoxia on established PHT cultures, the cells were plated for 24 hours before exposure to hypoxic or control conditions. Where indicated, cultures were supplemented with 25 to 400 mM cobalt chloride (Sigma-Aldrich, St Louis, MO). All individual fatty acids used in our assays were purchased from Sigma. Stock solutions of 100 and 200 mM of individual fatty acids and a 2:1 mixture of linoleic acid and oleic acid (LA/OA) were prepared in ethanol. Cells were exposed to a final concentration of 100 mM of various fatty acids or 0.1% ethanol as control for 24 hours after preincubation of fatty acids with serum-free medium containing 0.5% fatty acid-free BSA for 20 minutes at 37°C to allow the formation fatty acid-albumin complex. BeWo choriocarcinoma cells (60) were maintained in F12K Kaighn modified medium supplemented with 10% fetal bovine serum and antibiotics, and used as detailed in the following section.
Neutral lipid staining
After PBS washes, the cells were fixed in 2% paraformaldehyde for 20 minutes at room temperature (RT) because this fixation method has been previously optimized for retention of lipid content and lipid droplet structure (61) . Each plate was washed and the cells permeabilized with 1 mL of 0.1% Triton-X-100 in PBS for 5 minutes. Oil Red O staining was performed following our previously published protocol (62) . For fluorescence imaging, the wells were covered with borondipyrromethene (BODIPY) 493/503 (Molecular Probes, Eugene, OR) dissolved in ethanol for a stock solution of 0.1%, and further diluted to 10 mg/mL in PBS before assay (63) . After 15 minutes of exposure to BODIPY, the cells were washed in PBS. Nuclei were counterstained with TO-PRO 3-iodide 642/ 661 (Molecular Probes, 1:200 dilution) for 20 minutes, 4 0 ,6-diamidino-2-phenylindole (DAPI; Sigma, 1:50,000 dilution) for 3 minutes, or propidium iodide 3 mM in PBS for 3 minutes, and rinsed in PBS. The total fluorescence from neutral lipids was measured using a fluorometer (Packard Instrument Company, Meriden, CT) with excitation/emission wavelengths of 492/520 (BODIPY) or 360/460 (DAPI), or plates were mounted with GelMount (Biomeda, Foster City, CA) and viewed under a Nikon E800 microscope equipped with epifluorescence optics and a Nikon C1 confocal imaging package (Nikon, Japan). Some preparations were also plated on coverslips coated with 0.01% poly-Lysine (Sigma) in a 24-or 12-well plate, processed as described previously, and mounted in a drop of mount medium with SlowFade Gold antifading agent (Thermo Fisher, Waltham, MA). Images were captured using a 360 lens plus 31 to 32 digital zoom Eclipse Ti fluorescent microscope, equipped with Nikon's A1 laser confocal system. Slices of 0.4 mm Z-stack images were flattened using maximum intensity projection and analyzed by NIS-Elements (Nikon).
Lipid content assays
Tissues were homogenized in 2 mL of distilled water. Likewise, trophoblasts cultured in 10-cm plates under standard conditions or under hypoxia for 48 hours were washed in PBS followed by trypsinization for 2 minutes. Detached cells were collected, centrifuged for 5 minutes, and the medium aspirated. Remaining cell pellets (wet weight averaging 200 mg) from control and hypoxia samples were lysed in 2 mL of distilled water. From each 2-mL tube, a 50-mL sample was obtained for determination of protein concentration by the Lowry method (Bio-Rad, Hercules, CA). Lipids were extracted by chloroform/methanol (2:1, v/v). The lower organic phase was aspirated and evaporated to dryness. Lipids were dissolved in isopropanol. Contents of triglyceride, total cholesterol, phospholipids, and nonesterified fatty acids (NEFAs) were determined using respective Wako test kits (Wako Chemicals, Richmond, VA) according to the manufacturer's instructions. The results were normalized by protein content.
Fatty acid uptake assay
The uptake of fatty acid into PHT cells was measured using the fluorescent long chain fatty acid analog C 1 -BODIPY 500/510 -C 12 (Molecular Probes). BODIPY uptake medium consisted of 80 mM fatty acid-free BSA and 2.5 nM BODIPY in Hanks balanced salt solution. PHT cells were cultured in six-well plates for 24 hours under standard conditions, and then an additional 24 hours in either standard or hypoxic atmospheres. The cells were then incubated 1 hour at 37°C in serum-free DMEM, rinsed, and 800 mL of transport medium was added to each well and incubated at RT for 3 minutes. The uptake was stopped by the addition of 3.5 mL/well ice-cold stop solution [0.1% fatty acid-free BSA, 500 mM phloretin (Sigma) in PBS]. The cells were rinsed, lysed, and fluorescence measured on a Packard FluoroCount Microplate Fluorometer and expressed as relative fluorescence units. Nonspecific association of labeled fatty acid with trophoblasts was determined using duplicate cultures assayed in the presence of 500 mM phloretin, which blocks receptor-mediated fatty acid transport and was included in the preincubation, prewash, and fatty acid transport buffers in parallel cultures. Relative fluorescence was normalized to nuclei that were stained for 3 minutes with 0.1 mg/mL DAPI in PBS and quantified as noted earlier.
Fatty acid oxidation assay
Measurement of fatty acid oxidation was performed as previously described (64) . Briefly, PHT cells were cultured in 12-well plates for 24 hours under standard conditions, then washed and cultured overnight in triplicate in either standard or hypoxic conditions (O 2 ,1%). The wells were rinsed with Ca/Mg-free PBS and then incubated 2 hours at 37°C in 200 mL buffer consisting of 3 H-palmitic acid, 125 mM unlabeled palmitic acid, 2.5 mg/mL fatty acid-free BSA, and 1 mM carnitine in PBS. All washes and incubations were done in the respective atmospheres, using buffers pre-equilibrated to standard or hypoxic conditions. After incubation, the supernatants were removed, precipitated with 200 mL cold 10% trichloroacetic acid, centrifuged 10 minutes at 2200g at 4°C; 350 mL of supernatant was then neutralized with 55 mL 6 M NaOH and loaded onto 1 mL Dowex 1X2-400 ion exchange resin. The column was eluted into a scintillation vial with 1.7 mL distilled water. Ten milliliters of scintillation fluid was added to each vial and counted. Cells were lysed overnight in 220 mL 1 M NaOH, total protein determined using the Bio-Rad DC protein assay kit, and results expressed as nanomoles of 3 H-palmitic acid oxidized per hour per milligram protein.
Fatty acid efflux assay
Cells were plated in 12-well plates and incubated 24 hours under standard conditions. One hour before the addition of radiolabeled arachidonic acid labeling medium, etomoxir (100 mM final concentration) was added to the wells to inhibit fatty acid b-oxidation. The medium was then changed to medium containing 100 mM etomoxir (Sigma), 10 mM unlabeled arachidonic acid (Nu-Chek Prep, Elysian, MN), plus 1 mCi/mL [ 3 H]-arachidonic acid (Amersham Biosciences, Piscataway, NJ) and incubated 18 hours under standard conditions. For experiments using palmitic acid, 100 mM unlabeled palmitic acid (Nu-Chek Prep) and 10 mCi/mL [ 3 H]-palmitic acid (PerkinElmer, Waltham, MA) were used. At the end of the loading incubation, the wells were rinsed with warm basal medium and then in complete medium containing 100 mM etomoxir under either standard or hypoxic conditions (O 2 ,1%). Hypoxic medium was equilibrated 24 hours to remove residual oxygen. Culture supernatants were collected from triplicate wells at 2, 4, 8, and 24 hours after loading. For 24-hour samples, the cultures were spiked with an additional 100 mM etomoxir to ensure continued inhibition of b-oxidation. After collecting the supernatant, trophoblasts were lysed in 1 mL 20% SDS. Radioactivity in the supernatants and cell lysates was determined by scintillation counting as described previously. Percent efflux was determined by dividing supernatant counts by the total counts in the supernatant plus cell lysate.
RNA extraction and RT-quantitative PCR
Total RNA was extracted from PHT cultures using TRI Reagent (Molecular Research Center, Cincinnati, OH) according to the manufacturer's instructions, with added DNase (Thermo), and RT and quantitative PCR was performed in 96-or 384-well plates as previously described (50, 62) . Samples were compared with a control sample by the 2 2DDCT method (65). The 3-monooxygenase/ tryptophan 5-monooxygenase activation protein, zeta polypeptide, was used as a control transcript (66) . The specificity of amplification was confirmed using a dissociation curve of each PCR product. All primer sequences are provided in an online repository (67) .
Nuclear run-on
PHT cells were exposed to standard or hypoxic conditions as described earlier. The cells were scraped in PBS, lysed in 10 mM Tris-HCl, pH 7.4, containing 0.5% NP40 (68) , and their nuclei isolated in lysis buffer without NP-40 on ice. In vitro RNA synthesis was performed as described (69) . Briefly, cells were incubated with a transcription buffer containing ribonuclease ATP, ribonuclease GTP, and ribonuclease CTP (Promega, Madison, WI), and added Biotin-UTP (Roche) in 29°C. The reaction was stopped in a buffer containing CaCl and RNase-free DNase I (Roche). RNA was extracted in TRI Reagent as described previously, and newly synthesized, Biotin-labeled RNA was captured using streptavidin paramagnetic particles (Promega). The RNA was eluted and measured using RT-quantitative PCR.
Western immunoblotting and densitometric analysis
Cells were washed and lysed in 50 mM Tris-buffered saline (TBS)/1% Triton X-100 (USB, Cleveland, OH) and protease inhibitor (Halt Protease Inhibitor Cocktail; Thermo), pH 7.4. Plates were scraped, proteins extracted on ice for 15 minutes, and debris removed by centrifugation. Total protein concentration was measured as detailed earlier. Extracted proteins (10 to 40 mg) from whole cell lysate were separated by SDS-PAGE electrophoresis and transferred to polyvinylidene difluoride membranes (Bio-Rad) as previously described (53, 70) . Blots were blocked with 50 mM TBS with 0.1% Tween-20 (TBST, Thermo) containing 5% nonfat milk for 1 hour and incubated overnight at 4°C with mouse monoclonal anti-PLIN2 antibody (71), guinea pig polyclonal anti-PLIN3 antibody (72), or goat polyclonal anti-b-actin antibody (73). Antibodies were diluted in TBST containing 5% nonfat milk. For detection of PARP1, we used a mouse anti-PARP1 antibody (74), 4°C overnight; for detection of cleaved caspase 3, we used rabbit anti-C1 (cleaved) caspase 3 (75). After washing with TBST, the membranes were incubated with the corresponding horseradish peroxidaseconjugated secondary antibodies at RT for 2 hours. Chemiluminescent signal was detected by SuperSignal West Pico (Thermo) and quantified by densitometry using VisionWorks LS image acquisition and analysis software (UVP BioImaging, Upland, CA).
Immunofluorescence
After washes in PBS, the cells were fixed in 2% paraformaldehyde (76) for 20 minutes at RT. The cells permeabilized with 1 mL of 0.1% Triton-X-100 in PBS for 5 minutes. PHT cells were then stained with anti-PLIN2 antibody (detailed previously) and a Cy5-conjugated secondary antibody. All incubations were carried out in PBS containing 0.1% Tween 20, 0.02% sodium azide, and 0.2% BSA. Signals were visualized using the Nikon C1 confocal imaging package. Lipid droplets and nuclei were quantified from digital images using ImageJ software (National Institutes of Health, Bethesda, MD).
Small interfering RNA-mediated knockdown or overexpression of PLIN proteins
Linearized plasmid cytomegalovirus DNA 6.2-GW/ EmGFP-miRNA (miR) vector was purchased from Invitrogen (Life Technologies). Precursor miRNA sequences homologous to regions within the 3 0 UTR of human PLIN2 or PLIN3 were designed using the BLOCK-iT RNAi Designer (Thermo). The obtained target sequences showed no homology to other human proteins as determined by BLAST analysis. A negative control sequence supplied by Invitrogen and not predicted to target any known vertebrate gene was used to generate oligonucleotide pairs, which were cloned into the pcDNA 6.2-GW/EmGFP-miR. The vectors, pcDNA 6.2-GW/EmGFP-miR-PLIN2 and -PLIN3 were sequenceverified. All miR silencing sequences are provided in an online repository (67) . The precursor miRNA expression cassettes were PCR-amplified, inserted into the XhoI/MluI site in lentivirus vector pLemiR (Open Biosystems, Thermo) under the control of a cytomegalovirus promoter, and sequenceverified. The pLemiR constructs expressed the red fluorescent protein TurboRFP (Evrogen, Moscow, Russia) and a puromycin resistance marker. Transfection was detected by the TurboRFP signal. 293T cells were plated in a 15-cm dish coated with 0.1% gelatin for 16 hours before transfection. At 70% to 80% confluence, the medium was replaced with 10 mL Opti-MEM (Life Technologies) and transfected with 9.2 mg pLTRG (Addgene, #17532) (77), 13.2 mg pCD-NLBH*DDD (Addgene, #17531) (78), and 18 mg pLemiR, using 323.2 mL 7.5 nmol N/mL linear polyethylenimine (PEI; Polysciences, Warrington, PA) with a neutron/proton ratio of 20 (79) . The three plasmids were mixed with 150 mM NaCl (1.5 mL/dish). PEI was also added to 150 mM NaCl (1.5 mL/ dish) in a separate tube. The linear PEI/NaCl and plasmid/ NaCl solutions were mixed and incubated for 20 minutes at RT to form DNA/PEI complexes. The mixture (3 mL/dish) was added directly to the culture medium. After 6 hours' incubation at 37°C, the medium was replaced with complete medium. Lentivirus-containing culture medium was harvested at 48 and 72 hours after transfection, followed by filtration through a 0.45-mm filter. The virus was collected by ultracentrifugation at 18,000g for 2 hours at 4°C, resuspended in cold PBS (40 mL/dish), and stored at 280 C. To determine viral titer, BeWo cells were plated in a 24-well plate at a density of 50,000 cells/well. The medium was replaced by serial dilutions of lentivirus (10 22 to 10 29 ) in Opti-MEM at 0.5 mL/well and incubated for 6 hours. TurboRFP + colonies were counted under an inverted fluorescence microscope (Axiovert 40 CFL; Carl Zeiss, Oberkochen, Germany) at 72 hours after transfection, and the titer of the lentiviral stocks (transduction units per milliliter) was calculated by the number of positive colonies 3 lentiviral dilution factor. The lentiviral titers from 3 different miRNA constructs were 10 9 to 10 10 transduction units and used to estimate the multiplicity of infection (MOI).
For silencing of PLIN2 or PLIN3, the PHT medium was replaced the next day by the respective silencing lentivirus construct containing Opti-MEM at MOI = 100, required for efficient transfection of PHT cells, or a 1:1 mixture of PLIN2 and PLIN3 knockdown (kd) vectors (MOI = 50 each), incubated for 6 hours, and changed to complete medium. Transfection efficiency of PHT cells was 60% to 80%. The silencing experiments were reproduced using BeWo cells (not shown) using MOI = 10, stably selected with puromycin (5 mg/mL; InvivoGen, San Diego, CA), and confirmed as an efficient kd by western blot.
For overexpression of PLIN2, we used a plasmid systems previously described (58) . Briefly, the GFP-Plin2 fusion sequence was cut from plasmid PLA4 [a kind gift from TargettAdams et al. (80) ] using Nhe I and Kpn I. The released sequence was blunt ligated at the BamHI site in an FCIV lentiviral vector. This construct allows the expression of the fusion protein GFP-PLIN2, under the control of human ubiquitin promoter, and the GFP downstream of the internal ribosome entry site. Overexpression was performed as previously described (58).
Cell viability assay
Cell viability after PLIN protein manipulation was assessed using the MTS CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega) according to the manufacturer's instructions. Briefly, PLIN2-overexpressing trophoblasts were exposed to palmitic acid or arachidonic acid for 24 hours. MTS substrate was added at a ratio of 20 mL of MTS for every 100 mL of culture medium. After 1.5 hours of incubation, 50 mL medium from each well was analyzed in triplicate on a colorimetric plate reader (Molecular Devices, Sunnyvale, CA) at 490 nm.
DNA content
The cells were washed with PBS, and DNA extraction was performed with a DNeasy kit (Qiagen, Valencia, CA) as described in the manufacturer's instructions. Total DNA in each well was determined using NanoDrop 1000 (Thermo).
Statistics
All experiments were repeated at least three times. Data are presented as means 6 SD where relevant. Statistical significance was determined by Student t test or ANOVA with Holm post hoc analysis, using GraphPad Prism6 (GraphPad Software, La Jolla, CA). P , 0.05 was determined to be significant.
Results
Hypoxia causes lipid accumulation in PHTs
We initially assessed the impact of hypoxia on fat accumulation in PHT cells. We exposed these cells, derived from term placentas after healthy pregnancy, labor, and delivery, to hypoxia (24 to 72 hours, O 2 # 1%), and determined lipid accumulation using the lipophilic fluorescent dye BODIPY 493/503. This exposure led to an increase in the number of lipid droplets over the 72 hours of culture (Fig. 1A-1B) (67) . The increase in lipid accumulation did not stem from hindered trophoblast differentiation when cultured in hypoxic conditions (17) because using medium that delayed trophoblast differentiation into multinucleated syncytiotrophoblasts (81) had no effect on lipid droplet accumulation (Fig. 1C) . Lipid droplet accumulation in hypoxic trophoblasts was confirmed using Oil Red O staining (Fig. 1D) . Consistent with our observations and in vitro analysis, term placental villi derived from pregnancies complicated by hypoperfusion-related FGR exhibited more Oil Red O positive lipids compared with placental villi derived from uncomplicated term pregnancies (Fig. 2) .
Lipid droplets contain triglycerides as well as NEFA, cholesterol, and phospholipids (32) . To assess the type of lipids that accumulate in hypoxic trophoblasts in vitro and in vivo, we extracted total lipids from PHT cells cultured in standard and hypoxic conditions and from placental biopsies derived from pregnancies complicated by hypoperfusion-related FGR and from normal placentas. We found that only triglycerides were significantly upregulated by hypoxia in vitro (Fig. 3A , P , 0.001) or in vivo (Fig. 3B , P , 0.05), with no change in other types of lipids. Taken together, these data indicate that hypoxia enhances the accumulation of lipid droplets in human trophoblasts and that the increased lipid content mainly reflects the accumulation of triglycerides.
Hypoxia diminishes the efflux of fatty acids from trophoblasts
Several mechanisms might contribute to accumulation of triglycerides in trophoblasts, including increased uptake and synthesis of fatty acids, reduced b-oxidation, or reduced efflux. (i) To determine whether hypoxia increases the uptake of fatty acids, we incubated PHT cells in standard or hypoxic conditions (O 2 # 1%) and analyzed the uptake of the fluorescent long-chain fatty acid analog C 1 -BODIPY 500/510-C 12 (Molecular Probes). As shown in Fig. 4A , hypoxia had an insignificant effect on the uptake by trophoblasts. We obtained similar results using radioactively labeled oleic acid (not shown). (ii) We also found that the expression of fatty acid synthase and acyl-CoA carboxylase 1, two key transcripts upregulated during de novo fatty acid synthesis (82), was insignificantly reduced in trophoblasts cultured under hypoxic conditions (Fig. 4B) . In addition, the expression of SREBP members SREBP1a and SREBP2, transcription factors involved in cholesterol, fatty acid, and triglyceride biogenesis, was reduced (SREBP1a) or unchanged (SREBP2) in hypoxic trophoblasts (67) . (iii) Because b-oxidation requires oxygen and is known to be reduced in hypoxia (83), we predictably found that the rate of fatty acid b-oxidation in trophoblasts cultured in hypoxia was reduced (Fig. 4C) . (iv) We used radiolabeled arachidonic or palmitic acid in the presence of the inhibitor of fatty acid oxidation etomoxir (84) to assess the effect of hypoxia on the rate of fatty acid efflux from trophoblasts. As shown in Fig. 4D , hypoxia diminished the efflux of palmitic and arachidonic acid from trophoblasts. Notably, ,1% of the counts in the culture supernatants were derived from shorter fatty acids, indicating that etomoxir effectively blocked fatty acid oxidation. Together, these data indicate that the accumulation of triglycerides in trophoblasts likely reflects reduced efflux as well as the predicted reduction in b-oxidation.
PLIN2 is upregulated and colocalized with lipid droplets in hypoxic trophoblasts
We previously found that, among the PLIN family of lipid droplet proteins, only PLIN2 and PLIN3 transcripts were expressed in the human and mouse placenta (50) . Moreover, using mRNA microarray, we showed that the transcript for PLIN2 mRNA was markedly upregulated in hypoxic trophoblasts (18) . We confirmed Quantification of lipid content is described in Fig. 3 .
that the expression of PLIN2 was upregulated by fatty acids, as previously shown (85) , with stronger activation by longer chain fatty acids (67, 86) . As shown in Fig. 5A -5B, we confirmed that hypoxia was associated with upregulation of PLIN2 protein. In contrast, the level of PLIN3 was unchanged (Fig. 5A) . A similar, concentration-dependent increase was observed with the hypoxia-mimetic chemical CoCl (Fig. 5C) . Using a nuclear run-on approach, we confirmed that PLIN2 mRNA was newly synthesized in trophoblasts exposed to hypoxia (Fig. 5D ). Using immunofluorescence, we also determined that PLIN2 protein colocalized with trophoblastic BODIPY-stained lipid droplets (Fig. 5E ), which we previously showed to contain more triglycerides when isolated from hypoxic PHT cells (87) . These hypoxic lipid droplets also express PLIN2 protein (67) . Together, our data support a link between hypoxiainduced lipid droplet accumulation and PLIN2 expression in trophoblasts.
PLIN2 is essential for trophoblastic lipid droplet formation and cell viability
To assess the role of PLIN2 and PLIN3 in trophoblastic lipid droplet formation, we silenced the expression of PLIN2, PLIN3, or both in PHT cells (Fig. 6A) and determined the viability of these cells when exposed to fatty acids. Although at standard culture conditions there was no effect (not shown), consistent with the low baseline expression of PLIN2 in trophoblasts, the addition of a mix of LA/OA (total 200 mM) markedly reduced cell viability in PHT cells that were deficient in PLIN2 expression, with no effect of PLIN3 kd and no difference between the effect of PLIN2 or PLIN2/3 kd (Fig. 6B) . Cell death was corroborated by reduced DNA content in PLIN2-deficient PHT cells exposed to the LA/OA mix (Fig. 6C) . The observed reduction in cell viability in PLIN2 or PLIN2/3 kd cells was associated with apoptosis, determined by enhanced cleavage of PARP and the expression of cleaved caspase 3 (Fig. 6D) . To further assess the role of PLIN2 in trophoblasts, we overexpressed PLIN2 in PHT cells and exposed these cells to the LA/OA mix. We found that overexpression of PLIN2 promoted lipid droplet accumulation and cell viability in cells exposed to the LA/OA mix ( Fig. 7A-7B ). Taken together, these observations indicate that PLIN2 is necessary for the formation of lipid droplets and trophoblast viability when exposed to fatty acids.
Discussion
We found that exposure of term PHT cells to hypoxia increases the number of cellular lipid droplets and the accumulation of triglycerides in PHT cells. Cells and tissues capable of lipid storage and metabolism accumulate lipid droplets and triglycerides after exposure to hypoxia (88) . For example, lipid droplet accumulation is evident in hypoxic cardiomyocytes after experimentally induced infarct in murine or canine hearts (89), attributed to inhibition of mitochondrial fatty acid oxidation (83) . Although we previously reported the presence of lipid droplets in hypoxic trophoblasts (19) , the pathways underlying this response have not been investigated. We observed greater accumulation of lipid droplets in placental villi from pregnancies complicated by FGR; these have been associated with fibrin deposits, characteristic of accelerated villous maturation (90) and villous repair (91) . These in vivo observations were recently corroborated by others (92) . Importantly, NEFA might be toxic to the cells even at low concentrations (93) . They are prone to oxidation and may increase cellular stress. In fact, fatty acid accumulation in nonadipose tissues is implicated in the pathogenesis of diverse metabolic diseases (94) (95) (96) . Incorporation of NEFA into triglycerides and subsequent triglyceride accumulation in lipid droplets plays an important role in cellular protection against lipotoxicity (88, 97, 98) . Although we did not attempt to distinguish between lipid droplet accumulation in cytotrophoblasts and syncytiotrophoblasts, it has been found that the abundance of lipid droplets was similar in cytotrophoblasts and syncytiotrophoblasts and between the sexes, yet early esterification of fatty acids into triglycerides was more pronounced in cytotrophoblasts (99) .
Our data indicate that decreased fatty acid oxidation and efflux contribute to fat accumulation in hypoxic trophoblasts. Hypoxia-induced reduction in fatty acid oxidation, known to take place in the placenta (100), is not surprising because decreased oxygen supply decreases mitochondrial b-oxidation and increases glycolysis (101, 102) . The decrease in fatty acid efflux from trophoblasts exposed to hypoxia suggests a link between placental insufficiency and FGR; increased accumulation of fat in trophoblastic lipid droplets may protect the placenta against lipotoxicity, yet diminish the supply of fat for fetal growth and organ development. (41, 61, 106) . Interestingly, long-chain fatty acids induce PLIN2 expression in preadipocytes and human blood monocytes, likely through the activity of PPARg (86, 107, 108) . Indeed, PPARg is a key regulator of lipogenesis and of accumulation of lipid droplets in adipocytes and other cell types (109) . PPARg also upregulates trophoblastic PLIN2 in hypoxia (52) and trophoblastic lipid accumulation (62) , and administration of the PPARg ligand rosiglitazone to wild-type but not to Pparg-heterozygous pregnant mice causes accumulation of the long-chain fatty acid analog BMIPP in the placenta (54) . Further, several types of long-chain PUFA are known to stimulate the activity of PPARg (110, 111) . In contrast, ligand-activated PPARg or RXR did not affect trophoblastic fatty acid efflux, and lipid droplet accumulation was enhanced in Pparg-deficient mouse trophoblast stem cells exposed to hypoxia in a manner similar to control trophoblast stem cells (not shown). Thus, the role of trophoblastic PPARg in hypoxia-induced lipid accumulation awaits further investigation.
Our data support the notion that PLIN2, and not PLIN3, promotes trophoblast survival in hypoxia. We also showed that PLIN3 cannot compensate for reduced expression of PLIN2, and that a double PLIN2/3 kd had a phenotype similar to that of PLIN2 kd. Thus, the formation of triglycerides and their storage in lipid droplets can be viewed as a trophoblastic defense mechanism, in which excessive amounts of fatty acids could have deleterious effects on cell function and survival. Their packaging in neutral lipids within lipid droplets neutralizes those toxic effects and diminishes the risk of lipotoxicity (47) . Unique to the placenta, however, fat accumulation in trophoblastic lipid droplets and reduced efflux of FFA may adversely affect fetal growth and reduce fetal fat accretion (4-6). Although our results, obtained in PHT cells, are highly supportive of this balance, our experimental system does not reveal the directionality of efflux and other key parameters related to the fetal effect. In addition, excessive cell death limited our ability to test the effect of hypoxia in lentivirusexposed cells. Nonetheless, our study provides valuable information on the mechanisms by which hypoxia regulates fat accumulation in primary placental trophoblasts and may explain some of the pathways leading to the phenotype of FGR. The regulation of trophoblast lipid accumulation by lipases, lipase cofactors, and other lipid droplet-related proteins, such as G0S2, HIG-2, CG9186, and FIT1/FIT2 (112, 113) , remains to be determined. The viability of PHT cells when exposed to palmitic acid or oleic acid (200 mM each). Viability was determined in duplicate by MTS assay, as described in "Materials and Methods" (*P , 0.01, n = 3).
